__timestamp | Ionis Pharmaceuticals, Inc. | Viatris Inc. |
---|---|---|
Wednesday, January 1, 2014 | 20140000 | 1499100000 |
Thursday, January 1, 2015 | 37173000 | 1923500000 |
Friday, January 1, 2016 | 48616000 | 2351400000 |
Sunday, January 1, 2017 | 108488000 | 2564000000 |
Monday, January 1, 2018 | 244622000 | 2397300000 |
Tuesday, January 1, 2019 | 287000000 | 2503400000 |
Wednesday, January 1, 2020 | 354000000 | 3344600000 |
Friday, January 1, 2021 | 186000000 | 4529200000 |
Saturday, January 1, 2022 | 151000000 | 4179100000 |
Sunday, January 1, 2023 | 232600000 | 4650100000 |
Monday, January 1, 2024 | 267474000 |
Unleashing the power of data
In the competitive landscape of pharmaceuticals, understanding operational efficiency is crucial. Over the past decade, Ionis Pharmaceuticals, Inc. and Viatris Inc. have showcased contrasting trends in their Selling, General, and Administrative (SG&A) expenses. From 2014 to 2023, Ionis saw a significant increase in SG&A expenses, peaking in 2020 with a 1,660% rise from 2014. Meanwhile, Viatris consistently maintained higher SG&A expenses, reflecting its larger scale, with a notable 210% increase over the same period.
These trends highlight the strategic differences between the two companies, offering valuable insights for investors and industry analysts alike.
Comparing SG&A Expenses: Viatris Inc. vs Summit Therapeutics Inc. Trends and Insights
Cost Management Insights: SG&A Expenses for Viatris Inc. and Insmed Incorporated
Who Optimizes SG&A Costs Better? Viatris Inc. or Madrigal Pharmaceuticals, Inc.
Viatris Inc. vs Exelixis, Inc.: SG&A Expense Trends
Viatris Inc. or Arrowhead Pharmaceuticals, Inc.: Who Manages SG&A Costs Better?
Cost Management Insights: SG&A Expenses for Viatris Inc. and Evotec SE
Intra-Cellular Therapies, Inc. vs Ionis Pharmaceuticals, Inc.: SG&A Expense Trends
Cost Management Insights: SG&A Expenses for Sarepta Therapeutics, Inc. and Ionis Pharmaceuticals, Inc.
SG&A Efficiency Analysis: Comparing Exelixis, Inc. and Ionis Pharmaceuticals, Inc.
Jazz Pharmaceuticals plc and Ionis Pharmaceuticals, Inc.: SG&A Spending Patterns Compared
Breaking Down SG&A Expenses: Ionis Pharmaceuticals, Inc. vs Bausch Health Companies Inc.
Selling, General, and Administrative Costs: Ionis Pharmaceuticals, Inc. vs Mesoblast Limited